|Last Price||Today's Change||52-Week Range||Trading Volume|
|2.01||0.23 (+12.92%)||1.26 - 7.58||9.9 million (Above Avg)|
Market data as of 1:27PM 01/28/15. Quotes are delayed by at least 15 min.
Exelixis Analyst Report: Riding the Evolutions Issued by BrokerBank Securities, Inc.
01/05/2015 7:00 AM ET
Exelixis’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma
12/15/2014 1:00 AM ET